Literature DB >> 18059142

Recombinant tetra-cell adhesion motifs supports adhesion, migration and proliferation of keratinocytes/fibroblasts, and promotes wound healing.

Mi Yeon Jung1, Narendra Thapa, Jung Eun Kim, Jung Duk Yang, Byung Chae Cho, In San Kim.   

Abstract

An extracellular matrix protein plays an important role in skin wound healing. In the present study, we engineered a recombinant protein encompassing the 9(th) and 10(th) type III domains of fibronectin, and 4(th) FAS1 domain of betaig-h3. This recombinant protein, in total, harbors four known-cell adhesion motifs for integrins: Pro-His-Ser-Arg-Asn (PHSRN) and Arg-Gly-Asp (RGD) in 9(th) and 10(th) type III domains of fibronectin, respectively, and Glu-Pro-Asp-Ile-Met (EPDIM) and Try-His (YH) in 4(th) FAS1 domain of betaig-h3, were designated to tetra-cell adhesion motifs (T-CAM). In vitro studies showed T-CAM supporting adhesion, migration and proliferation of different cell types including keratinocytes and fibroblasts. In an animal model of full-thickness skin wound, T-CAM exhibited excellent wound healing effects, superior to both 4(th) FAS1 domain of betaig-h3 or 9(th) and 10(th) type III domains of fibronectin. Based on these results, T-CAM can be applied where enhancement of cell adhesion, migration and proliferation are desired, and it could be developed into novel wound healing drug.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059142     DOI: 10.1038/emm.2007.72

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  2 in total

1.  T-CAM, a fastatin-FIII 9-10 fusion protein, potently enhances anti-angiogenic and anti-tumor activity via alphavbeta3 and alpha5beta1 integrins.

Authors:  Ju-Ock Nam; Mi-Yeon Jung; Narendra Thapa; Byung-Heon Lee; Rang-Woon Park; In-San Kim
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

2.  Expression patterns of betaig-h3 in chondrocyte differentiation during endochondral ossification.

Authors:  Min-Su Han; Jung-Eun Kim; Hong-In Shin; In-San Kim
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.